Form 4 · Filed May 21, 2026, 08:05 PM UTC
INO/INOVIO PHARMACEUTICALS, INC.
Sumner Michael John — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 20, 2026 | M | other | 9,450 | — | — | 44,731 |
| May 20, 2026 | F | other | 2,693 | $1 | $3,312 | 42,038 |
| May 20, 2026 | M | other | 9,450 | — | — | 18,900 |
| May 20, 2026 | A | other | 46,876 | — | — | 46,876 |
| May 20, 2026 | A | other | 37,684 | — | — | 37,684 |
Source: SEC EDGAR raw filing ↗ · Accession 0001936799-26-000006